[Cytomegalovirus (CMV) infection: a frequent and life-threatening complication in heart transplant patients].
We investigated the clinical relevance of cytomegalovirus infection in our heart transplant recipients (n = 48). There was a high incidence of CMV-infection in patients where IgG positive donor versus IgG negative recipient was present. A total of 5/8 patients (= 62.5%) showed severe clinical CMV-infection with pneumonitis, colitis or tonsillitis besides general malaise, requiring long hospital treatment (2 to 24 weeks). CMV-infection is a frequent and threatening complication in patients after heart transplant (HTPL). We discuss the various managements in diagnosis, prophylaxis and treatment.
Mohacsi
P
P
Medizinische Klinik, Universitätsspital Zürich.
Leonardi
L
L
Waser
M
M
Lüthy
A
A
Laske
A
A
Turina
M
M
Gallino
A
A
D000914:Antibodies, Viral / Q000032:analysis; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000175:diagnosis*; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D009894:Opportunistic Infections / Q000175:diagnosis*; D011183:Postoperative Complications / Q000175:diagnosis*; D011379:Prognosis
D000914:Antibodies, Viral; D007074:Immunoglobulin G
Zytomegalievirus-(CMV-) Infektion: eine häufige und bedrohliche Komplikation bei Herztransplantationspatienten.